Global gene expression profiling of the polyamine system in suicide completers

International Journal of Neuropsychopharmacology

Volumn 14, Issue 5, 2011, Pages 595-605

  Fiori, Laura M ^a   Bureau, Alexandre ^b   Labbe, Aurélie ^c   Croteau, Jordie ^b   Nol, Simon ^b   Mérette, Chantal ^b   Turecki, Gustavo ^a  

^a MCGILL UNIVERSITY   (Canada)

^b LAVAL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

Gene expression; mood disorders; polyamines; post mortem; suicide

Indexed keywords

ADENOSYLMETHIONINE DECARBOXYLASE; ALDEHYDE DEHYDROGENASE; ANTIZYME; ARGINASE; ARGININE TRANSFER RNA LIGASE; ASPARTATE AMINOTRANSFERASE; CREATINE KINASE; GLYCINE AMIDINOTRANSFERASE; SPERMIDINE N1 ACETYLTRANSFERASE; SPERMINE N1 ACETYLTRANSFERASE; SPERMINE OXIDASE; SPERMINE SYNTHASE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BRAIN REGION; CONTROLLED STUDY; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; MALE; MOOD DISORDER; NEUROBIOLOGY; POLYAMINE METABOLISM; PRIORITY JOURNAL; SUICIDE;

ADENOSYLMETHIONINE DECARBOXYLASE; ASPARTATE AMINOTRANSFERASES; CHROMOSOME MAPPING; DNA, COMPLEMENTARY; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; MALE; MICROARRAY ANALYSIS; MOOD DISORDERS; OXIDOREDUCTASES ACTING ON CH-NH GROUP DONORS; POLYAMINES; SPERMIDINE; SPERMINE SYNTHASE; SUICIDE;

EID: 79956017507     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145710001574     Document Type: Article

References (57)

1. Ara AI, Xia M, Ramani K, Mato JM, et al. (2008). S-adenosylmethionine inhibits lipopolysaccharide-induced gene expression via modulation of histone methylation. Hepatology 47, 1655-1666. (Pubitemid 351702748)
2. Aston C, Jiang L, Sokolov BP (2005). Transcriptional profiling reveals evidence for signaling and oligodendroglial abnormalities in the temporal cortex from patients with major depressive disorder. Molecular Psychiatry 10, 309-322. (Pubitemid 40432684)
3. Benjamini Y, Hochberg Y (1995). Controlling the false discovery rate - a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society Series B: Methodological 57, 289-300.
4. Bird ED, Vonsattel JP (1993). The development of a brain bank. Journal of Neural Transmission (Suppl.) 39, 17-23. (Pubitemid 23216925)
5. Bo P, Giorgetti A, Camana C, Savoldi F (1990). EEG and behavioural effects of polyamines (spermine and spermidine) on rabbits. Pharmacological Research 22, 481-491. (Pubitemid 20265026)
6. Chen GG, Fiori LM, Moquin L, Gratton A, et al. (2010). Evidence of altered polyamine concentrations in cerebral cortex of suicide completers. Neuropsychopharmacology 35, 1477-1484.
7. Cui X, Hwang JT, Qiu J, Blades NJ, et al. (2005). Improved statistical tests for differential gene expression by shrinking variance components estimates. Biostatistics 6, 59-75. (Pubitemid 41240370)
8. Duranton B, Keith G, Goss F, Bergmann C, et al. (1998). Concomitant changes in polyamine pools and DNA methylation during growth inhibition of human colonic cancer cells. Experimental Cell Research 243, 319-325. (Pubitemid 28488842)
9. Efron B (2004). Large-scale simultaneous hypothesis testing: the choice of a null hypothesis. Journal of the American Statistical Association 99, 96-104. (Pubitemid 38545197)
10. Elgun S, Kumbasar H (2000). Increased serum arginase activity in depressed patients. Progress in Neuro-Psychopharmacology & Biological Psychiatry 24, 227-232. (Pubitemid 30159531)
11. Ernst C, Mechawar N, Turecki G (2009). Suicide neurobiology. Progress in Neurobiology 89, 315-333.
12. Fiori LM, Mechawar N, Turecki G (2009). Identification and characterization of SAT1 promoter variants in suicide completers. Biological Psychiatry 66, 460-467.
13. Fiori LM, Turecki G (2010a). Association of the SAT1 In/del polymorphism with suicide completion. American Journal of Medical Genetics B: Neuropsychiatric Genetics 153B, 825-829.
14. Fiori LM, Turecki G (2010b). Gene expression profiling of suicide completers. European Psychiatry 25, 287-290.
15. Fiori LM, Turecki G (2010c). Genetic and epigenetic influences on expression of spermine synthase and spermine oxidase in suicide completers. International Journal of Neuropsychopharmacology 13, 725-736.
16. Friedman DL, Roberts R (1994). Compartmentation of brain-type creatine kinase and ubiquitous mitochondrial creatine kinase in neurons: evidence for a creatine phosphate energy shuttle in adult rat brain. Journal of Comparative Neurology 343, 500-511. (Pubitemid 24129556)
17. Frostesjo L, Holm I, Grahn B, Page AW, et al. (1997). Interference with DNA methyltransferase activity and genome methylation during F9 teratocarcinoma stem cell differentiation induced by polyamine depletion. Journal of Biological Chemistry 272, 4359-4366. (Pubitemid 27078511)
18. Galea E, Regunathan S, Eliopoulos V, Feinstein DL, et al. (1996). Inhibition of mammalian nitric oxide synthases by agmatine, an endogenous polyamine formed by decarboxylation of arginine. Biochemical Journal 316, 247-249.
19. Gilad GM, Gilad VH (2003). Overview of the brain polyamine-stress- response: regulation, development, and modulation by lithium and role in cell survival. Cellular and Molecular Neurobiology 23, 637-649. (Pubitemid 37071490)
20. Gilad GM, Gilad VH, Wyatt RJ (1992). Polyamines modulate the binding of GABAA-benzodiazepine receptor ligands in membranes from the rat forebrain. Neuropharmacology 31, 895-898.
21. Guidotti A, Ruzicka W, Grayson DR, Veldic M, et al. (2007). S-adenosyl methionine and DNA methyltransferase-1 mRNA overexpression in psychosis. Neuroreport 18, 57-60. (Pubitemid 46183390)
22. Guipponi M, Deutsch S, Kohler K, Perroud N, et al. (2009). Genetic and epigenetic analysis of SSAT gene dysregulation in suicidal behavior. American Journal of Medical Genetics B: Neuropsychiatric Genetics 150B, 799-807.
23. Hemmer W, Wallimann T (1993). Functional aspects of creatine kinase in brain. Developmental Neuroscience 15, 249-260. (Pubitemid 24258157)
24. Hirsch SR, Richardson-Andrews R, Costall B, Kelly ME, et al. (1987). The effects of some polyamines on putative behavioural indices of mesolimbic vs. striatal dopaminergic function. Psychopharmacology (Berlin) 93, 101-104. (Pubitemid 17143734)
25. Katz S, Irizarry RA, Lin X, Tripputi M, et al. (2006). A summarization approach for Affymetrix GeneChip data using a reference training set from a large, biologically diverse database. BMC Bioinformatics 7, 464.
26. Kaufman L, Rousseeuw PJ (1990). Finding Groups in Data: An Introduction to Cluster Analysis. New York : Wiley-Interscience.
27. Kim C, Lesage A, Seguin M, Chawky N, et al. (2003). Patterns of co-morbidity in male suicide completers. Psychological Medicine 33, 1299-1309. (Pubitemid 37265217)
28. Klempan TA, Rujescu D, Merette C, Himmelman C, et al. (2009a). Profiling brain expression of the spermidine/ spermine N(1)-acetyltransferase 1 (SAT1) gene in suicide. American Journal of Medical Genetics B: Neuropsychiatric Genetics 150B, 934-943.
29. Klempan TA, Sequeira A, Canetti L, Lalovic A, et al. (2009b). Altered expression of genes involved in ATP biosynthesis and GABAergic neurotransmission in the ventral prefrontal cortex of suicides with and without major depression. Molecular Psychiatry 14, 175-189.
30. Lee BH, Lee SW, Yoon D, Lee HJ, et al. (2006). Increased plasma nitric oxide metabolites in suicide attempters. Neuropsychobiology 53, 127-132. (Pubitemid 43854170)
31. Liu W, Saint DA (2002). A new quantitative method of real time reverse transcription polymerase chain reaction assay based on simulation of polymerase chain reaction kinetics. Analytical Biochemistry 302, 52-59. (Pubitemid 34174608)
32. Mangold U (2005). The antizyme family: polyamines and beyond. IUBMB Life 57, 671-676. (Pubitemid 41564303)
33. Martins-de-Souza D, Gattaz WF, Schmitt A, Novello JC, et al. (2009a). Proteome analysis of schizophrenia patients Wernicke's area reveals an energy metabolism dysregulation. BMC Psychiatry 9, 17.
34. Martins-de-SouzaD,Gattaz WF, Schmitt A,RewertsC, et al. (2009b). Prefrontal cortex shotgun proteome analysis reveals altered calcium homeostasis and immune system imbalance in schizophrenia. European Archives of Psychiatry and Clinical Neuroscience 259, 151-163.
35. Maycox PR, Kelly F, Taylor A, Bates S, et al. (2009). Analysis of gene expression in two large schizophrenia cohorts identifies multiple changes associated with nerve terminal function. Molecular Psychiatry 14, 1083-1094.
36. Mischoulon D, Fava M (2002). Role of S-adenosyl-L-methionine in the treatment of depression: a review of the evidence. American Journal of Clinical Nutrition 76, 1158S-1161S. (Pubitemid 35244695)
37. Morgan PF, Stone TW (1983). Structure-activity studies on the potentiation of benzodiazepine receptor binding by ethylenediamine analogues and derivatives. British Journal of Pharmacology 79, 973-977.
38. Morris Jr. SM (2009). Recent advances in arginine metabolism: roles and regulation of the arginases. British Journal of Pharmacology 157, 922-930.
39. Nock MK, Borges G, Bromet EJ, Cha CB, et al. (2008). Suicide and suicidal behavior. Epidemiologic Reviews 30, 133-154.
40. Nolte J (2002). The Human Brain: An Introduction to its Functional Neuroanatomy (5th edn). St Louis: Mosby Inc.
41. Oldendorf WH, Szabo J (1976). Amino acid assignment to one of three blood-brain barrier amino acid carriers. American Journal of Physiology 230, 94-98.
42. Pegg AE (2009). Mammalian polyamine metabolism and function. IUBMB Life 61, 880-894.
43. Reif A, Jacob CP, Rujescu D, Herterich S, et al. (2009). Influence of functional variant of neuronal nitric oxide synthase on impulsive behaviors in humans. Archives of General Psychiatry 66, 41-50.
44. Reis DJ, Regunathan S (2000). Is agmatine a novel neurotransmitter in brain? Trends in Pharmacological Sciences 21, 187-193. (Pubitemid 30243201)
45. Rizzo WB, Craft DA (1991). Sjogren-Larsson syndrome. Deficient activity of the fatty aldehyde dehydrogenase component of fatty alcohol:NAD+ oxidoreductase in cultured fibroblasts. Journal of Clinical Investigation 88, 1643-1648.
46. Schipper RG, Van Den Heuvel LP, Verhofstad AA, De Abreu RA (2007). Polyamines and DNA methylation in childhood leukaemia. Biochemical Society Transactions 35, 331-335. (Pubitemid 46596502)
47. Schulze A (2003). Creatine deficiency syndromes. Molecular and Cellular Biochemistry 244, 143-150. (Pubitemid 36411067)
48. Sequeira A, Gwadry FG, Ffrench-Mullen JM, Canetti L, et al. (2006). Implication of SSAT by gene expression and genetic variation in suicide and major depression. Archives of General Psychiatry 63, 35-48. (Pubitemid 43037467)
49. Sequeira A, Klempan T, Canetti L, Ffrench-Mullen J, et al. (2007). Patterns of gene expression in the limbic system of suicides with and without major depression. Molecular Psychiatry 12, 640-655. (Pubitemid 46998251)
50. Shin WW, Fong WF, Pang SF, Wong PC (1985). Limited blood-brain barrier transport of polyamines. Journal of Neurochemistry 44, 1056-1059. (Pubitemid 15105755)
51. Vockley JG, Jenkinson CP, Shukla H, Kern RM, et al. (1996). Cloning and characterization of the human type II arginase gene. Genomics 38, 118-123. (Pubitemid 26424589)
52. Williams A, Girard C, Jui D, Sabina A, et al. (2005). S-adenosylmethionine (SAMe) as treatment for depression: a systematic review. Clinical and Investigative Medicine 28, 132-139. (Pubitemid 40978708)
53. Williams K (1997). Modulation and block of ion channels: a new biology of polyamines. Cellular Signalling 9, 1-13. (Pubitemid 27120861)
54. Wu H, Kerr MK, Cui X, Churchill GA (2003). MAANOVA: a software package for the analysis of spotted cDNA microarray experiments. In: Parmigiani G, Garrett ES, Irizarry RA, Zeger SL (Eds), The Analysis of Gene Expression Data: Methods and Software. New York: Springer.
55. Wyss M, Kaddurah-Daouk R (2000). Creatine and creatinine metabolism. Physiological Reviews 80, 1107-1213. (Pubitemid 30452013)
56. Yanik M, Vural H, Kocyigit A, Tutkun H, et al. (2003). Is the arginine-nitric oxide pathway involved in the pathogenesis of schizophrenia? Neuropsychobiology 47, 61-65. (Pubitemid 36469841)
57. Yanik M, Vural H, Tutkun H, Zoroglu SS, et al. (2004). The role of the arginine-nitric oxide pathway in the pathogenesis of bipolar affective disorder. European Archives of Psychiatry and Clinical Neuroscience 254, 43-47. (Pubitemid 39310548)